ABEONA THERAPEUTICS INC (ABEO) Stock Earnings & Estimates
NASDAQ:ABEO - US00289Y2063 - Common Stock
7.11 USD
+0.1 (+1.43%)
7.07 USD
-0.04 (-0.56%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3M -70.00% | 1.41M -53.00% | 3.5M 148.23% | 102K -100.00% | 27.073M | 119.02M 339.63% | 206.42M 73.43% | 309.84M 50.10% | 388.13M 25.27% | 446.38M 15.01% | 486.95M 9.09% | 497M 2.06% | |
| EBITDA YoY % growth | -54.12M -23.25% | -42.17M 22.08% | -45.002M -6.72% | N/A -36.23% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -57.37M -18.29% | -45.26M 21.11% | -48.2M -6.50% | -65.255M -33.22% | -58.709M 8.57% | 3.61M 106.15% | 74.219M 1,955.93% | 120.25M 62.02% | 176.34M 46.64% | 217.7M 23.45% | 246.07M 13.03% | 249M 1.19% | |
| Operating Margin | -1,912.33% | -3,209.93% | -1,377.14% | -63,975.60% | -216.86% | 3.03% | 35.96% | 38.81% | 45.43% | 48.77% | 50.53% | 50.10% | |
| EPS YoY % growth | -15.75 -14.55% | -5.53 64.89% | -2.71 50.99% | -1.79 35.79% | -0.10 94.37% | 0.12 217.56% | 1.15 903.01% | 2.05 77.56% | 2.40 17.16% | 2.84 18.26% | 3.17 11.67% | 3.35 5.47% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.06 109.25% | -0.09 36.85% | -0.10 57.50% | -0.05 89.90% | 0.00 -104.38% | 0.08 189.42% |
| Revenue Q2Q % growth | 6.428M | 21.306M | 24.028M | 25.979M 6,394.75% | 28.835M 348.58% | 31.593M 48.28% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -16.71M -8.90% | -5.641M 66.16% | -7.372M 62.63% | -6.023M 73.57% | -4.359M 73.91% | -3.115M 44.79% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.53 -378.95% | -0.39 | -0.14 | -36.14% |
| Q1 2025 Q2Q % growth | -0.24 79.31% | -0.37 | 0.13 | 35.41% |
| Q4 2024 Q2Q % growth | -0.14 81.82% | -0.36 | 0.22 | 61.23% |
| Q3 2024 Q2Q % growth | -0.63 -31.25% | -0.41 | -0.22 | -52.88% |
| Q2 2024 Q2Q % growth | 0.19 120.65% | -0.37 | 0.56 | 151.17% |
| Q1 2024 Q2Q % growth | -1.16 -114.81% | -0.52 | -0.64 | -121.54% |
| Q4 2023 Q2Q % growth | -0.77 -150.33% | -0.48 | -0.29 | -60.62% |
| Q3 2023 Q2Q % growth | -0.48 67.57% | -0.54 | 0.06 | 10.65% |
| Q2 2023 Q2Q % growth | -0.92 55.77% | -0.69 | -0.23 | -32.64% |
| Q1 2023 Q2Q % growth | -0.54 84.57% | -0.59 | 0.05 | 8.72% |
| Q4 2022 Q2Q % growth | 1.53 143.71% | -0.77 | 2.30 | 300.00% |
| Q3 2022 Q2Q % growth | -1.48 63.00% | -1.78 | 0.30 | 16.93% |
| Q2 2022 Q2Q % growth | -2.08 48.00% | -1.91 | -0.17 | -8.76% |
| Q1 2022 Q2Q % growth | -3.50 17.65% | -2.42 | -1.08 | -44.48% |
| Q4 2021 Q2Q % growth | -3.50 17.65% | -3.74 | 0.24 | 6.42% |
| Q3 2021 Q2Q % growth | -4.00 -100.00% | -4.14 | 0.14 | 3.47% |
| Q2 2021 Q2Q % growth | -4.00 -14.29% | -4.21 | 0.21 | 4.93% |
| Q1 2021 Q2Q % growth | -4.25 -6.25% | -4.76 | 0.51 | 10.72% |
| Q4 2020 Q2Q % growth | -4.25 43.33% | -2.55 | -1.70 | -66.67% |
| Q3 2020 Q2Q % growth | -2.00 77.14% | -3.65 | 1.65 | 45.28% |
| Q2 2020 Q2Q % growth | -3.50 71.43% | -4.34 | 0.84 | 19.26% |
| Q1 2020 Q2Q % growth | -4.00 58.97% | -6.23 | 2.23 | 35.79% |
| Q4 2019 Q2Q % growth | -7.50 | -7.91 | 0.41 | 5.12% |
| Q3 2019 Q2Q % growth | -8.75 | -11.11 | 2.36 | 21.25% |
| Q2 2019 Q2Q % growth | -12.25 | -8.91 | -3.34 | -37.41% |
| Q1 2019 Q2Q % growth | -9.75 | -8.11 | -1.64 | -20.15% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 102K | -102K | -100.00% | |
| Q3 2024 Q2Q % growth | 102K | -102K | -100.00% | |
| Q2 2024 Q2Q % growth | -100.00% | 84.997K | -84.997K | -100.00% |
| Q1 2024 Q2Q % growth | 170.003K | -170.003K | -100.00% | |
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q2 2023 Q2Q % growth | 3.5M 250.00% | 3.5M | % | |
| Q1 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | 70K -97.67% | 1.02M | -950K | -93.14% |
| Q4 2021 Q2Q % growth | 3M | 3M | % | |
| Q3 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | 3M | 5.474M | -2.474M | -45.20% |
| Q3 2020 Q2Q % growth | 7M | 1.19M | 5.81M | 488.24% |
| Q3 2019 Q2Q % growth | 102K | -102K | -100.00% | |
| Q2 2019 Q2Q % growth | 236.895K | -236.895K | -100.00% | |
| Q1 2019 Q2Q % growth | 794.07K | -794.07K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -58.69% | 117.06% | 76.92% | 32.24% |
| Revenue | -4.66% | 65.84% | 5.71% | 19.07% |